RT Journal Article
SR Electronic
A1 Alexander, Walter
T1 MITRE: No Benefit for Continuous Glucose Monitoring Devices
JF MD Conference Express
YR 2007
FD SAGE Publications
VO 7
IS 6
SP 12
OP 20
DO 10.1177/155989770700700610
UL http://mdc.sagepub.com/content/7/6/12.abstract
AB The Minimally Invasive Technology Role and Evaluation [MITRE] Study, a randomized controlled trial of continuous glucose monitoring device use, showed them to be of no greater benefit than standard care. This article discusses the report that all groups, including controls, had a sustained reduction of HbA1C.